Supplementary Table S6: TCR Clones and Pathologic Response in HNSCC Immunotherapy

Supplementary Table S6 from a study on dual immune checkpoint inhibitor therapy for head and neck squamous cell carcinoma. The table likely contains data on preexisting T-cell receptor clones, specifically comparing super-expanders between patients with major pathologic response and non-responders. Authored by Huaibin Ge and shared under a CC-BY-4.0 license, this 9.1 KB CSV file was last updated on June 1, 2026.

Use Cases

• Identify T-cell receptor clones associated with positive clinical outcomes based on the comparison of super-expanders between responder groups.
• Analyze the overlap of TCR repertoires between different patient subgroups based on the description of 'ovlp_MPRvsNR'.
• Investigate potential biomarkers for predicting response to dual immune checkpoint inhibitor therapy based on preexisting TCR clone data.

Strengths

• Data is openly licensed under CC-BY-4.0, allowing for broad reuse.
• The dataset is focused on a specific and clinically relevant comparison between patient response groups.

Limitations

• The dataset is very small at 9.1 KB, indicating limited scope.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

figshare

Freshness

Last updated 2026-06-01 07:24:48; freshness should be verified.